Public annual accounts

YMED financials

Name: YMED financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for YMED, with comparable measures and links to available source documents.

Company overview

Registry number

0732743740

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for YMED

2025 versus 2024

Operating line: €78,569
EBITDA: €54,843
Total assets: €334,309
Equity: €226,482

EBITDA margin +69.8% · Equity ratio +67.7%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€78,569	€54,843	€334,309	€226,482	-
202431 Dec 2024	€79,655	€78,254	€346,183	€198,878	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report